,"This is a citation overview for a set of 316 documents.",,,,,,,,,,,,
,,,,,,,,,,,,,
,"h index = 37 (Of the 316 documents considered for the h-Index, 37 have been cited at least 37 times.)",,,,,,,,,,,,
,Note: Scopus does not have complete citation information for articles published before 1996.  ,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,<2010,2010,2011,2012,subtotal,>2012,total
Publication Year,Document Title,Authors,ISSN,Journal Title,Volume,Issue,8392,989,882,245,2116,0,10508
2009,"Gene-centric Association Signals for Lipids and Apolipoproteins Identified via the HumanCVD BeadChip","Talmud P.J., Li K., Casas J.P., Sofat R., Kumari M., Rodriguez S., Johnson T., Newhouse S.J., Dominiczak A., Samani N.J., Caulfield M., Drenos F., Sever P., Stanton A., Shields D.C., Padmanabhan S., Melander O., Hastie C., Delles C., Ebrahim S., Marmot M.G., Smith G.D., Shah S., Lawlor D.A., Munroe P.B., Day I.N., Kivimaki M., Whittaker J., Humphries S.E., Hingorani A.D., Shah T., Palmen J., Verzilli C., Gaunt T.R., Pallas J., Lovering R.",00029297,"American Journal of Human Genetics",85, 5,0,12,26,5,43,0,43
2009,"Atorvastatin treatment is associated with less augmentation of the carotid pressure waveform in hypertension: A substudy of the anglo-scandinavian cardiac outcome trial (ASCOT)","Manisty C., Mayet J., Tapp R.J., Sever P.S., Poulter N., McG. Thom S.A., Hughes A.D.",0194911X,"Hypertension",54, 5,2,5,3,1,9,0,11
2009,"Baseline Heart Rate, Antihypertensive Treatment, and Prevention of Cardiovascular Outcomes in ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial)","Poulter N.R., Dobson J.E., Sever P.S., Dahlof B., Wedel H., Campbell N.R.C.",07351097,"Journal of the American College of Cardiology",54, 13,1,11,8,3,22,0,23
2009,"Is systolic blood pressure all that matters? Yes.","Sever P.",14685833,"BMJ (Clinical research ed.)",339, ,0,2,0,0,2,0,2
2009,"Differential effects of antihypertensive treatment on the retinal microcirculation: An anglo-scandinavian cardiac outcomes trial substudy","Thom S., Stettler C., Stanton A., Witt N., Tapp R., Chaturvedi N., Allemann S., Mayet J., Sever P., Poulter N., O'Brien E., Hughes A.",0194911X,"Hypertension",54, 2,1,2,2,2,6,0,7
2009,"Managing cardiovascular and renal risk: The potential of direct renin inhibition","Sever P.S., Gradman A.H., Azizi M.",14703203,"JRAAS - Journal of the Renin-Angiotensin-Aldosterone System",10, 2,5,19,12,1,32,0,37
2009,"Is systolic blood pressure all that matters? Yes","Sever P.",17561833,"BMJ (Online)",339, 7713,0,0,1,0,1,0,1
2009,"Coronary heart disease benefits from blood pressure and lipid-lowering","Sever P.S., Poulter N.R., Mastorantonakis S., Chang C.L., Dahlof B., Wedel H.",01675273,"International Journal of Cardiology",135, 2,0,1,0,0,1,0,1
2009,"Antihypertensive therapy and the benefits of atorvastatin in the Anglo-Scandinavian Cardiac Outcomes Trial: Lipid-lowering arm extension","Sever P.S., Poulter N.R., Dahlof B., Wedel H.",02636352,"Journal of Hypertension",27, 5,2,8,3,1,12,0,14
2009,"The lifetime cost effectiveness of amlodipine-based therapy plus atorvastatin compared with atenolol plus atorvastatin, amlodipine-based therapy alone and atenolol-based therapy alone: Results from ASCOT","Lindgren P., Buxton M., Kahan T., Poulter N.R., Dahlof B., Sever P.S., Wedel H., Jonsson B.",11707690,"PharmacoEconomics",27, 3,0,4,1,0,5,0,5
2009,"Effect of Beta Blockers (Metoprolol or Propranolol) on Effect of Simvastatin in Lowering C-Reactive Protein in Acute Myocardial Infarction","Quinaglia e Silva J.C., Munhoz D.B., Morato T.N., Gurgel A., Macedo A.C.T., Sever P., Sposito A.C.",00029149,"American Journal of Cardiology",103, 4,1,0,0,1,1,0,2
2008,"10 steps before you refer for hypertension","Sever P.",09696113,"British Journal of Cardiology",15, 6,0,0,0,0,0,0,0
2008,"Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials","Turnbull F., Woodward M., Neal B., Barzi F., Ninomiya T., Chalmers J., Perkovic V., Li N., MacMahon S., Agodoa L., Anderson C., Asselbergs F.W., Baigent C., Black H., Brenner B., Brown M., Bulpitt C., Byington R., Chalmers J., Collins R., Cutler J., Dahlof B., Davis B., De Zeeuw D., Dens J., Estacio R., Fagard R., Fox K., Fukui T., Hansson L., Holman R., Hunsicker L., Imai Y., Ishii M., Kanno Y., Kostis J., Kuramoto K., Lewis E., Lievre M., Lindholm L.H., Liu L., Lubsen J., Lueders S., Malacco E., Mancia G., Matsuzaki M., Neal B., Nissen S., Ohkubo T., Ogihara T., Palmer C., Pepine C., Pfeffer M., Pitt B., Poole-Wilson P., Poulter N., Rahman M., Remme W., Remuzzi G., Rodgers A., Ruggenenti P., Saruta T., Schrader J., Schrier R., Sever P., Sleight P., Staessen J., Suzuki H., Teo K., Van Gilst W.H., Viberti G., Wang J., Whelton P., Wing L., Yui Y., Yusuf S., Zanchetti A.",0195668X,"European Heart Journal",29, 21,12,12,17,3,32,0,44
2008,"The Anglo-Scandinavian Cardiac Outcomes Trial: Blood pressure-lowering limb: Effects in patients with type II diabetes","Ostergren J., Poulter N.R., Sever P.S., Dahlof B., Wedel H., Beevers G., Caulfield M., Collins R., Kjeldsen S.E., Kristinsson A., McInnes G.T., Mehlsen J., Nieminen M., OBrien E.",02636352,"Journal of Hypertension",26, 11,10,11,8,0,19,0,29
2008,"Ethnicity and Left Ventricular Diastolic Function in Hypertension. An ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial) Substudy","Sharp A., Tapp R., Francis D.P., McG. Thom S.A., Hughes A.D., Stanton A.V., Zambanini A., Chaturvedi N., Byrd S., Poulter N.R., Sever P.S., Mayet J.",07351097,"Journal of the American College of Cardiology",52, 12,2,5,3,0,8,0,10
2008,"Effect of doxazosin gastrointestinal therapeutic system as third-line antihypertensive therapy on blood pressure and lipids in the Anglo-Scandinavian cardiac outcomes trial","Chapman N., Chang C.L., Dahlof B., Sever P.S., Wedel H., Poulter N.R.",00097322,"Circulation",118, 1,7,8,3,2,13,0,20
2008,"Systolic pressure is all that matters","Williams B., Lindholm L.H., Sever P.",01406736,"The Lancet",371, 9631,34,17,14,3,34,0,68
2008,"Determinants of new-onset diabetes among 19,257 hypertensive patients randomized in the anglo-scandinavian cardiac outcomes trial-blood pressure lowering arm and the relative influence of antihypertensive medication","Gupta A.K., Dahlof B., Dobson J., Sever P.S., Wedel H., Poulter N.R.",01495992,"Diabetes Care",31, 5,18,11,17,3,31,0,49
2008,"The Anglo-Scandinavian Cardiac Outcomes Trial lipid lowering arm: Extended observations 2 years after trial closure","Sever P.S., McInnes G., Mehlsen J., Nieminen M.S., O'Brien E.T., Ostergren J., Poulter N.R., Dahlof B., Wedel H., Beevers G., Caulfield M., Collins R., Kjeldsen S.E., Kristinsson A.",0195668X,"European Heart Journal",29, 4,13,7,12,3,22,0,35
2008,"Economic evaluation of ASCOT-BPLA: antihypertensive treatment with an amlodipine-based regimen is cost effective compared with an atenolol-based regimen.","Lindgren P., Buxton M., Kahan T., Poulter N.R., Dahlof B., Sever P.S., Wedel H., Jonsson B.",1468201X,"Heart (British Cardiac Society)",94, 2,7,2,4,1,7,0,14
2007,"Response to spironolactone in resistant hypertension [2]","Chapman N., Dobson J., Wilson S., Dahlof B., Sever P.S., Wedel H., Poulter N.R.",0194911X,"Hypertension",50, 3,0,0,0,0,0,0,0
2007,"Blood pressure-dependent and independent effects of agents that inhibit the renin-angiotensin system","Agodoa L., Anderson C., Asseibergs F., Baigent C., Black H., Brenner B., Brown M., Bulpitt C., Byington R., Chalmers J., Collins R., Cutler J., Dahlof B., Davis B., De Zeeuw D., Dens J., Estacio R., Fagard R., Fox K., Fukui T., Hansson L., Holman R., Hunsicker L., Imai Y., Ishii M., Kanno Y., Kostis J., Kuramoto K., Lewis E., Lievre M., Lindholm L.H., Liu L., Lubsen J., Lueders S., MacMahon S., Malacco E., Mancia G., Matsuzaki M., Neal B., Nissen S., Ohkubo T., Ogihara T., Pepine C., Pfeffer M., Pitt B., Poole-Wilson P., Rahman M., Remme W., Remuzzi G., Rodgers A., Ruggenenti P., Saruta T., Schrader J., Schrier R., Sever P., Sleight P., Staessen J., Teo K., Viberti G., Wang J., Whelton P., Wing L., Yui Y., Yusuf S., Zanchetti A., Turnbull F., Neal B., Pfeffer M., Kostis J., Algert C., Woodward M., Chalmers J., Zanchetti A., MacMahon S.",02636352,"Journal of Hypertension",25, 5,105,27,34,7,68,0,173
2007,"Effect of spironolactone on blood pressure in subjects with resistant hypertension","Chapman N., Dobson J., Wilson S., Dahlof B., Sever P.S., Wedel H., Poulter N.R.",0194911X,"Hypertension",49, 4,85,44,37,15,96,0,181
2007,"Erratum: Potential synergy between lipid-lowering and blood-pressure- lowering in the Anglo-Scandinavian Cardiac Outcomes Trial (European Heart Journal (2006) 27 (2982-2988))","Sever P., McInnes G., Mehlsen J., Nieminem M., O'Brien E., Ostergren J., Dahlof B., Poulter N., Wedel H., Beevers G., Caulfield M., Collins R., Kjeldsen S., Kristinsson A.",0195668X,"European Heart Journal",28, 1,0,0,0,0,0,0,0
2006,"Potential synergy between lipid-lowering and blood-pressure-lowering in the Anglo-Scandinavian Cardiac Outcomes Trial","Sever P., McInnes G., Mehlsen J., Nieminem M., O'Brien E., Ostergren J., Dahlof B., Poulter N., Wedel H., Beevers G., Caulfield M., Collins R., Kjeldsen S., Kristinsson A.",0195668X,"European Heart Journal",27, 24,51,15,11,3,29,0,80
2006,"Candesartan- and atenolol-based treatments induce different patterns of carotid artery and left ventricular remodeling in hypertension","Ariff B., Zambanini A., Vamadeva S., Barratt D., Xu Y., Sever P., Stanton A., Hughes A., Thom S.",00392499,"Stroke",37, 9,19,4,1,1,6,0,25
2006,"It is not beyond the blood pressure; it is the blood pressure","Sever P.S., Poulter N.R., Elliott W.J., Jonsson M.C., Black H.R.",00097322,"Circulation",113, 23,1,0,0,0,0,0,1
2006,"Blood pressure reduction is not the only determinant of outcome","Sever P.S., Poulter N.R.",00097322,"Circulation",113, 23,33,1,3,0,4,0,37
2006,"New hypertension guidelines from the National Institute for Health and Clinical Excellence and the British Hypertension Society","Sever P.",14703203,"JRAAS - Journal of the Renin-Angiotensin-Aldosterone System",7, 2,40,13,4,3,20,0,60
2006,"Authors' reply [5]","Dahlof B., Sever P., Poulter N., Wedel H.",01406736,"Lancet",367, 9506,0,0,0,0,0,0,0
2005,"Lipid-lowering therapy and the patient with multiple risk factors: What have we learned from the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)?","Sever P.S.",00029343,"American Journal of Medicine",118, 12,9,3,0,1,4,0,13
2005,"Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA)","Tseng K.H., Poulter N.R., Sever P.S., Dahlof B., Wedel H.",01495992,"Diabetes Care",28, 10,3,1,0,0,1,0,4
2005,"Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): A multicentre randomised controlled trial","Dahlof B., Sever P.S., Poulter N.R., Wedel H., Beevers D.G., Caulfield M., Collins R., Kjeldsen S.E., Kristinsson A., McInnes G.T., Mehlsen J., Nieminen M., O'Brien E., Ostergren J.",01406736,"Lancet",366, 9489,878,197,159,39,395,0,1273
2005,"Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA)","Poulter N.R., Wedel H., Dahlof B., Sever P.S., Beevers D.G., Caulfield M., Kjeldsen S.E., Kristinsson A., McInnes G.T., Mehlsen J., Nieminen M., O'Brien E., Ostergren J., Pocock S.",01406736,"Lancet",366, 9489,172,25,17,7,49,0,221
2005,"Different time course for prevention of coronary and stroke events by atorvastatin in the anglo-scandinavian cardiac outcomes trial - lipid-lowering arm (ASCOT-LLA)","Sever P.S., Poulter N.R., Dahlof B., Wedel H.",00029149,"American Journal of Cardiology",96, 5,29,5,3,1,9,0,38
2005,"ASCOT a four horse race","Sever P.",14703203,"JRAAS - Journal of the Renin-Angiotensin-Aldosterone System",6, 2,1,0,1,0,1,0,2
2005,"Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA)","Sever P.S., McInnes G.T., Mehlsen J., Nieminen M., O'Brien E., Ostergren J., Poulter N.R., Dahlof B., Wedel H., Collins R., Beevers G., Caulfield M., Kjeldsen S.E., Kristinsson A.",01495992,"Diabetes Care",28, 5,129,14,19,10,43,0,172
2005,"Cost-effectiveness of atorvastatin for the prevention of coronary and stroke events: An economic analysis of the Anglo-Scandinavian Cardiac Outcomes Trial - Lipid-lowering arm (ASCOT-LLA)","Lindgren P., Buxton M., Kahan T., Poulter N.R., Dahlof B., Sever P.S., Wedel H., Jonsson B.",17418267,"European Journal of Cardiovascular Prevention and Rehabilitation",12, 1,22,4,1,2,7,0,29
2004,"Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial - Lipid Lowering Arm (ASCOT-LLA): A multicentre randomised controlled trial","Sever P.S., Dahlof B., Poulter N.R., Wedel H., Beevers G., Caulfield M., Collins R., Kjeldsen S.E., Kristinsson A., McInnes G.T., Mehlsen J., Nieminen M., O'Brien E., Ostergren J.",00126667,"Drugs",64, 2,33,5,7,1,13,0,46
2004,"The Second Lilly Prize Lecture, University of Newcastle, July 1977. ?-adrenergic receptor blockade in hypertension, past, present and future","Prichard B.N.C., Sever P.",03065251,"British Journal of Clinical Pharmacology",58, 7,0,0,0,0,0,0,0
2004,"The dawn of a new era in cardiovascular prevention | À l'aube d'une nouvell ère de prévention cardiovasculaire","Amouyel P., Mansourati J., Sever P., Girerd X.",07554982,"Presse Medicale",33, 16,0,0,0,0,0,0,0
2004,"VALUE: analysis of results.","Sever P.",1474547X,"Lancet",364, 9438,2,0,0,0,0,0,2
2004,"VALUE: Analysis of results [1]","Staessen J.A., Kario K., Pickering T., Fretheim A., Julius S., Weber M.A., Thijs L., Birkenhager W.H., Williams S.G., Barker D., Schlosshan D., Tan L.-B., Scheen A.J., Sever P.",01406736,"Lancet",364, 9438,15,0,1,0,1,0,16
2004,"The VALUE trial: A commentary","Sever P.",14703203,"JRAAS - Journal of the Renin-Angiotensin-Aldosterone System",5, 3,2,0,0,0,0,0,2
2004,"Regression of left ventricular mass in hypertensive patients treated with perindopril/indapamide as a first-line combination: The REASON echocardiography study","De Luca N., Battegay E., Duprez D., Sever P., Safar M.E., Mallion J.-M., O'Rourke M.F., O'Brien E., Rahn K.-H., Trimarco B., Romero R., De Leeuw P.W., Hitzenberger G.",08957061,"American Journal of Hypertension",17, 8,43,4,6,0,10,0,53
2004,"British hypertension society guidelines for hypertension management 2004 (BHS-IV): Summary","Williams B., Poulter N.R., Brown M.J., Davis M., McInnes G.T., Potter J.F., Sever P.S., Thom S.M.",09598146,"British Medical Journal",328, 7440,341,45,51,12,108,0,449
2004,"Guidelines for management of hypertension: Report of the fourth working party of the Bristish Hypertension Society, 2004 - BHS IV","Williams B., Poulter N.R., Brown M.J., Davis M., McInnes G.T., Potter J.F., Sever P.S., Thom S.McG.",09509240,"Journal of Human Hypertension",18, 3,518,80,64,22,166,0,684
2003,"ASCOT-LLA: Questions about the benefits of atorvastatin [3] (multiple letters)","Devroey D., Drummond G.A., Ginst L.V., Ravnskov U., Killestein J., Sever P.S., Dahlof B., Poulter N., Wedel H., Trewby P.",01406736,"Lancet",361, 9373,1,0,0,0,0,0,1
2003,"Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial - Lipid Lowering Arm (ASCOT-LLA): A multicentre randomised controlled trial","Sever P.S., Dahlof B., Poulter N.R., Wedel H., Beevers G., Caulfield M., Collins R., Kjeldsen S.E., Kristinsson A., McInnes G.T., Mehlsen J., Nieminen M., O'Brien E., Ostergren J.",01406736,"Lancet",361, 9364,1795,175,170,44,389,0,2184
2003,"ALLHAT: Definitive answers or continuing uncertainty?","Sever P.",14703203,"JRAAS - Journal of the Renin-Angiotensin-Aldosterone System",4, 1,0,0,0,0,0,0,0
2002,"A systematic approach to erectile dysfunction in the cardiovascular patient: A consensus treatment - Update 2002","Jackson G., Sever P., Betteridge J., Dean J., Eardley I., Hall R., Holdright D., Holmes S., Kirby M., Riley A.",13685031,"International Journal of Clinical Practice",56, 9,31,3,2,1,6,0,37
2002,"Hypertension trials - The current evidence base and forthcoming trials","Sever P., Poulter N.",09696113,"British Journal of Cardiology",9, 10,1,0,0,0,0,0,1
2002,"Introduction","Sever P.",14703203,"JRAAS - Journal of the Renin-Angiotensin-Aldosterone System",3, 1,0,0,0,0,0,0,0
2002,"The SCOPE trial","Sever P.",14703203,"JRAAS - Journal of the Renin-Angiotensin-Aldosterone System",3, 2,11,1,0,0,1,0,12
2002,"Comparison of the effects of antihypertensive treatment with angiotensin II blockade and beta-blockade on carotid wall structure and haemodynamics: Protocol and baseline demographics","Ariff B., Thom S.A.McG., Stanton A., Barratt D., Augst A., Glor F., Poulter N., Sever P., Xu Y., Hughes A.",14703203,"JRAAS - Journal of the Renin-Angiotensin-Aldosterone System",3, 2,6,1,1,0,2,0,8
2001,"Effects of blood pressure lowering with amlodipine or lisinopril on vascular structure of the common carotid artery","Stanton A.V., Chapman J.N., Mayet J., Sever P.S., Poulter N.R., Hughes A.D., Thom S.A.McG.",01435221,"Clinical Science",101, 5,22,3,3,0,6,0,28
2001,"Amelioration of arterial properties with a perindopril-indapamide very-low-dose combination.","Asmar R.G., Duprez D., De Leeuw P.W., Sever P., Battegay E., Hitzenberger G., de Luca N., Polonia P., Benetos A., Chastang C., Ollivier J.P., London G.M., Safar M.E., O'Rourke M.E., Mallion J.M., Romero R., Rahn K.H., Trimarco B., Fitzgerald D., Hedner T.",09521178,"Journal of hypertension. Supplement : official journal of the International Society of Hypertension",19, 4,23,1,0,0,1,0,24
2001,"Non-specific effects of inclusion in a clinical trial: Information from ASCOT","Thom S., Whitehouse A., Sever P., Poulter N.",09509240,"Journal of Human Hypertension",15, 1,0,0,0,0,0,0,0
2001,"Anglo-Scandinavian cardiac outcomes trial: A brief history, rationale and outline protocol","Sever P.S., Mehlsen J., Nieminen M., O'Brien E., Ostergren J., Dahlof B., Poulter N.R., Wedel H., Beevers G., Caulfield M., Collins R., Kjeldsen S.E., McInnes G.T.",09509240,"Journal of Human Hypertension",15, 1,22,1,1,0,2,0,24
2001,"An intensive phenotyping study to enable the future examination of genetic influences on hypertension-associated cardiovascular disease","Stanton A., Fitzgerald D., Hughes A., Mayet J., O'Brien E., Poulter N.R., Sever P.S., Shields D., Thom S.",09509240,"Journal of Human Hypertension",15, 1,4,2,0,0,2,0,6
2001,"Mechanism of action of angiotensin II in human isolated subcutaneous resistance arteries","Garcha R.S., Sever P.S., Hughes A.D.",00071188,"British Journal of Pharmacology",134, 1,14,1,0,0,1,0,15
2001,"Angiotensin receptor antagonists and vaso-vagal attacks due to sensitisation of the Bezold-Jarisch reflex?","Sever P.S., Hughes A.",09509240,"Journal of Human Hypertension",15, 6,0,0,0,0,0,0,0
2001,"Rationale, design, methods and baseline demography of participants of the Anglo-Scandinavian cardiac outcomes trial","Sever P.S., Mehlsen J., Nieminen M., O'Brien E., Ostergren J., Dahlof B., Poulter N.R., Wedel H., Beevers G., Caulfield M., Collins R., Kjeldsen S.E., McInnes G.T.",02636352,"Journal of Hypertension",19, 6,144,6,7,1,14,0,158
2001,"Hypertension in the very elderly trial (HYVET): Protocol for the main trial","Staessen J., Nachev C., Potter J., Sever P., Bulpitt C., Swift C., Fletcher A., Tuomilehto J., Beckett N., Coope J., Gil-Extremera B., Forette F.",1170229X,"Drugs and Aging",18, 3,81,6,4,2,12,0,93
2001,"Discordant responses to two classes of drugs acting on the renin-angiotensin system","Sever P.S., Chang C.L.",14703203,"JRAAS - Journal of the Renin-Angiotensin-Aldosterone System",2, 1,7,1,1,0,2,0,9
2000,"Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: Results of prospectively designed overviews of randomised trials","Neal B., MacMahon S., Chapman N., Cutler J., Fagard R., Whelton P., Yusuf S., Agodoa L., Baigent C., Black H., Boissel J.P., Brenner B., Brown M., Bulpitt C., Byington R., Chalmers J., Collins R., Dahlof B., Davis B., Estacio R., Fox K., Hansson L., Holman R., Hunsicker L., Kostis J., Kuramoto K., Kusek J., Lees R., Lewis E., Lindholm L.H., Liu L., Lubsen J., Malacco E., Mancia G., Martin I., Pepine C., Pfeffer M., Pitt B., Poole-Wilson P., Remuzzi G., Rodgers A., Ruggenenti P., Schrier R., Sever P., Sleight P., Staessen J., Teo K., Turner R., Wing L., Zanchetti A., Algert C., Woodward M.",01406736,"Lancet",356, 9246,943,78,48,10,136,0,1079
2000,"Action of angiotensin II on DNA synthesis by human saphenous vein in organ culture","Ibrahim J., Hughes A.D., Sever P.S.",0194911X,"Hypertension",36, 5,6,0,1,1,2,0,8
2000,"Improvement in midwall myocardial shortening with regression of left ventricular hypertrophy","Mayet J., Ariff B., Wasan B., Chapman N., Shahi M., Poulter N.R., Sever P.S., Foale R.A., Thom S.A.McG.",0194911X,"Hypertension",36, 5,21,2,2,2,6,0,27
2000,"To block the renin system or the calcium channel in hypertension--where do we stand?","Sever P.S.",14703203,"Journal of the renin-angiotensin-aldosterone system : JRAAS",1, 4,0,0,0,0,0,0,0
2000,"The do's and don'ts when using AIIRAs in daily practice in hypertension: An introduction","Sever P.S.",09509240,"Journal of Human Hypertension",14, 2,0,0,0,0,0,0,0
2000,"Hypertension drug trials: Past, present, and future","Sever P.S., Poulter N.R.",09509240,"Journal of Human Hypertension",14, 10-11,3,0,0,0,0,0,3
2000,"Applying evidence-based medicine to current practice: A round table panel discussion","McInnes G.T., Mancia G., Sever P.S., Poulter N.R.",09509240,"Journal of Human Hypertension",14, 2,0,0,0,0,0,0,0
2000,"Coronary heart disease prevention As the primary goal in contemporary trials in the treatment of hypertension.","Sever P.S.",15226417,"Current hypertension reports",2, 4,1,0,0,0,0,0,1
2000,"Absence of sympathetic overactivity in Afro-Caribbean hypertensive subjects studied by heart rate variability","Guzzetti S., Thom S.A.McG., Mayet J., Shahi M., Mezzetti S., Foale R.A., Sever P.S., Poulter N.R., Porta A., Malliani A.",09509240,"Journal of Human Hypertension",14, 5,10,1,0,1,2,0,12
2000,"ACE inhibitors in hypertension: Still a shortage of evidence","Sever P.",14703203,"JRAAS - Journal of the Renin-Angiotensin-Aldosterone System",1, 2,3,0,0,0,0,0,3
2000,"The surgical management of renovascular hypertension in children and young adults","Chalmers R.T.A., Dhadwal A., Deal J.E., Sever P.S.",10785884,"European Journal of Vascular and Endovascular Surgery",19, 4,13,2,5,0,7,0,20
2000,"Page's Syndrome: A case of pseudophaeochromocytoma","Chapman J.N., French A.T., Poulter N.R., Sever P.S.",09509240,"Journal of Human Hypertension",14, 2,2,0,0,0,0,0,2
2000,"The past, present and future of hypertension management: A potential role for AT1-receptor antagonists","Hollenberg N.K., Sever P.S.",14703203,"JRAAS - Journal of the Renin-Angiotensin-Aldosterone System",1, 1,12,1,0,0,1,0,13
2000,"Calcium channel blockers and hypertension - An ongoing saga","Sever P.S.",09696113,"British Journal of Cardiology",7, 11,0,0,0,0,0,0,0
2000,"Candesartan cilexetil: From concept to clinic. Proceedings of an international meeting held in Lisbon, Portugal, October 1998 - Foreword","Hollenberg N.K., Sever P.S.",08038023,"Blood Pressure, Supplement",9, 1,0,0,0,0,0,0,0
2000,"Erectile dysfunction in cardiovascular patients: A consensus statement | Erektile dysfunktion bei herz-kreislauf-patienten: Eine konsensus- stellungnahme","Jackson G., Betteridge J., Dean J., Hall R., Holdright D., Holmes S., Kirby M., Riley A., Sever P.",00467324,"Herz Kreislauf",32, 1,0,0,0,0,0,0,0
2000,"Improving antihypertensive efficacy while maintaining placebo-like tolerability","Sever P.S.",08038023,"Blood Pressure, Supplement",9, 1,0,0,1,0,1,0,1
1999,"Simple blood pressure guidelines for primary health care","Sever P.S.",09509240,"Journal of Human Hypertension",13, 11,14,0,0,0,0,0,14
1999,"A systematic approach to erectile dysfunction in the cardiovascular patient: A consensus statement","Jackson G., Betteridge J., Dean J., Hall R., Holdwright D., Holmes S., Kirby M., Riley A., Sever P.",13685031,"International Journal of Clinical Practice",53, 6,56,2,3,0,5,0,61
1999,"Action of AT1 receptor antagonists on angiotensin II-induced tone in human isolated subcutaneous resistance arteries","Garcha R.S., Sever P.S., Hughes A.D.",00071188,"British Journal of Pharmacology",127, 8,20,0,0,0,0,0,20
1999,"Low dose indapamide plus perindopril combination effects on cardiovascular structure and function in genetic hypertension","Ibrahim J., Schachter M., Hughes A.D., Sever P.S.",03051870,"Clinical and Experimental Pharmacology and Physiology",26, 8,4,0,0,0,0,0,4
1999,"Recent clinical trials: a critical appraisal.","Sever P.S.",15226417,"Current hypertension reports",1, 4,2,0,0,0,0,0,2
1999,"Audit of blood pressure control in a specialized hypertension clinic | Audit du traitement de I'hypertension arterielle en consultation specialisee","Tache A., Chatellier G., Azizi M., Sever P., Menard J.",00039683,"Archives des Maladies du Coeur et des Vaisseaux",92, 8,3,0,0,0,0,0,3
1999,"?1-blockers in hypertension","Sever P.S.",03007995,"Current Medical Research and Opinion",15, 2,7,0,1,0,1,0,8
1999,"QT dispersion in athletic left ventricular hypertrophy","Mayet J., Kanagaratnam P., Shahi M., Senior R., Doherty M., Poulter N.R., Sever P.S., Handler C.E., McG Thom S.A., Foale R.A.",00028703,"American Heart Journal",137, 4 I,20,1,1,1,3,0,23
1999,"Journal of Cardiovascular Pharmacology: Introduction","Sever P.S., Oparil S.",01602446,"Journal of Cardiovascular Pharmacology",33, 2,0,0,0,0,0,0,0
1999,"Additional therapy versus monotherapy in the treatment of hypertension","Sever P.S.",09696113,"British Journal of Cardiology",6, 1,3,0,0,0,0,0,3
1999,"Key features of candesartan cilexetil and a comparison with other angiotensin II receptor antagonists","Sever P.S.",09509240,"Journal of Human Hypertension",13, 1,21,0,0,0,0,0,21
1999,"Closing remarks","Sever P.",09509240,"Journal of Human Hypertension",13, 1,0,0,0,0,0,0,0
1999,"Discussion 2 (Part A)","Brenner T.M., Yamazaki T., Unger T., Sever P.S., Mallion J.-M.",09509240,"Journal of Human Hypertension",13, 1,0,0,0,0,0,0,0
1999,"Discussion 2 (Part B)","Sever P.S., Brenner M.B., Unger T., Kurokawa K.",09509240,"Journal of Human Hypertension",13, 1,0,0,0,0,0,0,0
1999,"The heterogeneity of hypertension","Sever P.S.",1520765X,"European Heart Journal, Supplement",1, L,6,0,0,0,0,0,6
1998,"Clinical implications of differences between angiotensin II antagonists","Sever P.S., Mancia G.",10880224,"American Journal of Managed Care",4, 7,0,0,0,0,0,0,0
1998,"Vein graft stenosis and the heparin responsiveness of human vascular smooth muscle cells","Refson J.S., Schachter M., Patel M.K., Hughes A.D., Munro E., Chan P., Wolfe J.H.N., Sever P.S.",00097322,"Circulation",97, 25,12,1,1,0,2,0,14
1998,"Why do black patients have big hearts?","Mayet J., Chapman N., Li C.K.-C., Shahi M., Poulter N.R., Sever P.S., Thom S.A.McG., Foale R.A.",13556037,"Heart",79, 1,0,0,0,0,0,0,0
1998,"Ethnic differences in the hypertensive heart and 24-hour blood pressure profile","Mayet J., Chapman N., Li C.K.-C., Shahi M., Poulter N.R., Sever P.S., Foale R.A., Thom S.A.McG.",0194911X,"Hypertension",31, 5,37,0,2,0,2,0,39
1998,"Action of losartan metabolite E-3174, tyrosine kinase inhibition and calcium channel blockade on angiotensin-II (AII) responses in human resistance arteries","Garcha R.S., Sever P.S., Hughes A.D.",08926638,"FASEB Journal",12, 5,0,0,0,0,0,0,0
1998,"Protocol for prospective collaborative overviews of major randomized trials of blood-pressure-lowering treatments","Black H., Boissel J.P., Brenner B., Brown M., Bulpitt C., Chalmers J., Collins R., Cutler J., Dahlof B., Davis B., Fagard R., Fletcher A., Furberg C., Hansson L., Kuramoto K., Lewis E., MacMahon S., Mancia G., Pitt B., Poulter N., Remuzzi G., Sleight P., Turner R., Sever P., Whelton P., Wing L., Yusuf S., Zanchetti A., Martin I., Cohn J., Alderman M., Hansson L., Neal B., Rodgers A., Baigent C., Collins R., MacMahon S.",02636352,"Journal of Hypertension",16, 2,62,4,4,0,8,0,70
1997,"Combination therapy: A key to comprehensive patient care","Kaplan N.M., Sever P.S.",08957061,"American Journal of Hypertension",10, 7,0,0,0,0,0,0,0
1997,"Combination therapy: A key to comprehensive patient care","Kaplan N.M., Sever P.S.",08957061,"American Journal of Hypertension",10, 7,0,0,0,0,0,0,0
1997,"Retinal vascular network architecture in low-birth-weight men","Chapman N., Mohamudally A., Cerutti A., Stanton A., Sayer A.A., Cooper C., Barker D., Rauf A., Evans J., Wormald R., Sever P., Hughes A., Thom S.",02636352,"Journal of Hypertension",15, 12 I,40,4,10,2,16,0,56
1997,"Clinical profile of the novel angiotensin II type I blocker candesartan cilexetil","Sever P.S.",09521178,"Journal of Hypertension, Supplement",15, 6,13,2,0,0,2,0,15
1997,"Blood pressure control for the hypertensive patient: What can we do better?","Sever P.S.",08957061,"American Journal of Hypertension",10, 7,15,0,1,0,1,0,16
1997,"Left ventricular hypertrophy, blood pressure and ACE genotype in untreated hypertension","Mayet J., Foale R.A., Webb D.J., Thom S.A.McG., O'Kane K.P.J., Elton R., Johnstone H.A., Shahi M., Ozkor M.A., Stanton A.V., Poulter N.R., Sever P.S.",09509240,"Journal of Human Hypertension",11, 9,7,0,1,1,2,0,9
1997,"Candesartan cilexetil: A new, long-acting, effective angiotensin II type 1 receptor blocker","Sever P.",09509240,"Journal of Human Hypertension",11, 2,37,2,2,0,4,0,41
1997,"Left ventricular geometry in presenting untreated hypertension","Mayet J., Shahi M., Poulter N.R., Sever P.S., Foale R.A., Thom S.A.McG.",09509240,"Journal of Human Hypertension",11, 9,4,0,0,0,0,0,4
1997,"Long-term efficacy and tolerability of candesartan cilexetil in patients with mild to moderate hypertension","Sever P., Holzgreve H.",09509240,"Journal of Human Hypertension",11, 2,30,1,0,0,1,0,31
1997,"Combination therapy: A key to comprehensive patient care","Kaplan N.M., Sever P.S.",08957061,"American Journal of Hypertension",10, 7,1,0,0,0,0,0,1
1997,"The effects on cardiac arrhythmias of antihypertensive therapy causing regression of left ventricular hypertrophy","Mayet J., Thom S.A.M., Chapman N., Shahi M., Poulter N.R., Cunningham D.A., Dave S., Kooner J., Sever P.S., Foale R.A.",08957061,"American Journal of Hypertension",10, 6,5,0,0,0,0,0,5
1996,"Action of losartan, PD-123,319 and endothelial factors on angiotensin-II (AU) responses in human resistance arteries","Garcha R.S., Schachter M., Sever P.S., Hughes A.D.",08926638,"FASEB Journal",10, 3,0,0,0,0,0,0,0
1996,"Salt - Overwhelming evidence but still no action: Can a consensus be reached with the food industry?","MacGregor G.A., Sever P.S.",09598146,"British Medical Journal",312, 7041,34,5,6,3,14,0,48
1996,"Radioligand-binding analysis of human prostatic alpha-1 adrenoreceptor density following transurethral microwave therapy","Bdesha A.S., Schachter M., Sever P., Witherow R.O.",00071331,"British Journal of Urology",78, 6,9,0,0,0,0,0,9
1996,"The hypertension trials","Sever P.S.",09521178,"Journal of Hypertension, Supplement",14, 2,11,0,0,0,0,0,11
1996,"Left ventricular hypertrophy and QT dispersion in hypertension","Mayet J., Shahi M., McGrath K., Poulter N.R., Sever P.S., Foale R.A., Thom S.A.McG.",0194911X,"Hypertension",28, 5,121,4,6,1,11,0,132
1996,"Arteriolar length-diameter (L:D) ratio: A geometric parameter of the retinal vasculature diagnostic of hypertension","King L.A., Stanton A.V., Sever P.S., Thom S.A., Hughes A.D.",09509240,"Journal of Human Hypertension",10, 6,23,4,1,0,5,0,28
1996,"Calcium channel blockers in the dock: Innocent or guilty?","Mackay J.A., Sever P.S.",09509240,"Journal of Human Hypertension",10, 5,5,0,0,0,0,0,5
1996,"Depletion of resistance vessel polyamines attenuates angiotensin II induced blood pressure rise in rats","Ibrahim J., Hughes A.D., Schachter M., Sever P.S.",10641963,"Clinical and Experimental Hypertension",18, 6,5,0,0,0,0,0,5
1996,"Thiazide-induced hyperglycaemia: A role for calcium-activated potassium channels?","Pickkers P., Schachter M., Hughes A.D., Feher M.D., Sever P.S.",0012186X,"Diabetologia",39, 7,4,1,0,0,1,0,5
1996,"Concomitant risk factors in hypertensives: A survey of risk factors for cardiovascular disease amongst hypertensives in English general practices","Poulter N.R., Zographos D., Mattin R., Sever P.S., Thom S.McG.",08037051,"Blood Pressure",5, 4,14,0,0,0,0,0,14
1996,"Enhanced tissue polyamine content in the spontaneously hypertensive rat","Ibrahim J., Hughes A.D., Schachter M., Sever P.S.",03051870,"Clinical and Experimental Pharmacology and Physiology",23, 5,7,1,0,0,1,0,8
1996,"Effect of angiotensin II on the expression of the early growth response gene c-fos and DNA synthesis in human vascular smooth muscle cells","Patel M.K., Betteridge L.J., Hughes A.D., Clunn G.F., Schachter M., Shaw R.J., Sever P.S.",02636352,"Journal of Hypertension",14, 3,29,0,1,0,1,0,30
1996,"Methodological aspects: General discussion","Mancia G., MacMahon S., Zanchetti A., Sever P.S., Lindholm L., Hansson L., Sleight P., Agabitei-Rosei E., Menard J., Salvetti A.",09521178,"Journal of Hypertension, Supplement",14, 2,0,0,0,0,0,0,0
1995,"An equivalence study of the safety and efficacy of a fixed-dose combination of perindopril with indapamide versus fixed-dose combinations of captopril with hydrochlorothiazide and enalapril with hydrochlorothiazide in the treatment of hypertension","Luccioni R., Sever P.S., Di Perri T., Redon J., Laurandin I., Brault Y., Chastang C., Guez D.",02636352,"Journal of Hypertension",13, 12,21,0,0,0,0,0,21
1995,"Do K(Ca) channels and carbonic anhydrase play a role in thiazide-induced hyperglycaemia?","Pickkers P., Schachter M., Sever P.S., Hughes A.D.",09509240,"Journal of Human Hypertension",9, 8,3,1,0,0,1,0,4
1995,"Left ventricular structure and function in previously untreated hypertensive patients: The importance of blood pressure, the nocturnal blood pressure dip and heart rate","Mayet J., Shahi M., Hughes A.D., Stanton A.V., Poulter N.R., Sever P.S., Foale R.A., McG. Thom A.",13506277,"Journal of Cardiovascular Risk",2, 3,14,0,0,0,0,0,14
1995,"Introduction","Sever P.",09509240,"Journal of Human Hypertension",9, 2,0,0,0,0,0,0,0
1995,"Differential mitogenic effects of PDGF isoforms and heparin on human vascular smooth muscle cells","Refson J.S., Schachter M., Patel M.K., Wolfe J.H.N., Sever P.",03005127,"Biochemical Society Transactions",23, 2,1,0,0,0,0,0,1
1995,"Role of polyamines in hypertension induced by angiotensin II","Ibrahim J., Scachter M., Hughes A.D., Sever P.S.",00086363,"Cardiovascular Research",29, 1,19,1,1,0,2,0,21
1995,"Structural changes in the cardiovascular system of untreated essential hypertensives","Hughes A.D., Sinclair A.-M., Geroulakos G., Mayet J., Mackay J., Shahi M., Thom S., Nicolaides A., Sever P.S.",08037051,"Blood Pressure",4, 1,10,0,0,0,0,0,10
1995,"The effects of antihypertensive therapy on carotid vascular structure in man","Mayet J., Stanton A.V., Sinclair A.-M., MacKay J., Shahi M., Foale R.A., Nicolaides A., Poulter N.R., Sever P.S., McG. Thom S.A., Hughes A.D.",00086363,"Cardiovascular Research",30, 1,33,0,1,0,1,0,34
1995,"Correlation of heparin binding with responsiveness in human vascular smooth muscle cells","Refson J.S., Schachter M., Patel M.K., Chan P., Wolfe J.H.N., Sever P.",03005127,"Biochemical Society Transactions",23, 2,3,0,0,0,0,0,3
1995,"Inhibition of human vascular smooth muscle cell proliferation by the novel multiple-action antihypertensive agent carvedilol","Patel M.K., Chan P., Betteridge L.J., Schachter M., Sever P.S.",01602446,"Journal of Cardiovascular Pharmacology",25, 4,29,0,0,1,1,0,30
1995,"Ventricular arrhythmias in hypertension: In which patients do they occur?","Mayet J., Shahi M., Poulter N.R., Sever P.S., Thom McG. S.A., Foale R.A.",02636352,"Journal of Hypertension",13, 2,21,0,0,0,0,0,21
1995,"The continuing challenge of hypertension","Sever P.",09509240,"Journal of Human Hypertension",9, 2,1,0,0,0,0,0,1
1995,"The heterogeneity of hypertension: Why doesn't every patient respond to every antihypertensive drug?","Sever P.",09509240,"Journal of Human Hypertension",9, 2,21,0,1,0,1,0,22
1994,"Inhibition of human vascular smooth muscle cell proliferation by lovastatin: The role of isoprenoid intermediates of cholesterol synthesis","Munro E., Sever P., Patel M., Chan P., Betteridge L., Clunn G., Gallagher K., Hughes A., Schachter M., Wolfe J.",00142972,"European Journal of Clinical Investigation",24, 11,81,2,0,0,2,0,83
1994,"The Hypertension in the Very Elderly Trial (HYVET)","Bulpitt C.J., Sever P., Staessen J., Swift C., Fletcher A.E., Amery A., Coope J., Evans J.G., Lightowlers S., O'Malley K., Palmer A., Potter J.",09509240,"Journal of Human Hypertension",8, 8,20,0,0,0,0,0,20
1994,"The Hypertension in the Very Elderly Trial (HYVET). Rationale, methodology and comparison with previous trials.","Bulpitt C.J., Sever P., Fletcher A.E., Amery A., Coope J., Evans J.G., Lightowlers S., O'Malley K., Palmer A., Potter J.",1170229X,"Drugs & aging",5, 3,58,0,0,0,0,0,58
1994,"Role of polyamines in hypertension induced by angiotensin II","Ibrahim J., Schachter M., Hughes A.D., Sever P.S.",00086363,"Cardiovascular Research",28, 9,0,0,0,0,0,0,0
1994,"Potassium channel opening properties of thiazide diuretics in isolated guinea pig resistance arteries","Calder J.A., Schachter M., Sever P.S.",01602446,"Journal of Cardiovascular Pharmacology",24, 1,15,1,0,0,1,0,16
1994,"Growth inhibition of human vascular smooth muscle cells by fenofibrate: A possible therapy for restenosis","Munro E., Patel M., Chan P., Betteridge L., Gallagher K., Schachter M., Wolfe J., Sever P.",00086363,"Cardiovascular Research",28, 5,10,0,1,0,1,0,11
1994,"Vasorelaxant actions of 5-OH-indapamide, a major metabolite of indapamide: Comparison with indapamide, hydrochlorothiazide and cicletanine","Calder J.A., Schachter M., Sever P.S.",00142999,"European Journal of Pharmacology",256, 2,10,2,0,0,2,0,12
1994,"Racial differences in cardiac structure and function in essential hypertension","Mayet J., Shahi M., Foale R.A., Poulter N.R., Sever P.S., Thom S.A.McG.",09598146,"British Medical Journal",308, 6935,53,1,2,1,4,0,57
1994,"Effect of calcium channel blockers on the growth of human vascular smooth muscle cells derived from saphenous vein and vascular graft stenoses","Munro E., Patel M., Chan P., Betteridge L., Gallagher K., Schachter M., Wolfe J., Sever P.",01602446,"Journal of Cardiovascular Pharmacology",23, 5,21,0,1,0,1,0,22
1994,"Low dose thiazide diuretic. May not lower blood pressure effectively [11]","Poulter N., Sever P., Chang L., Bell P.M.",09598146,"British Medical Journal",309, 6956,1,0,0,0,0,0,1
1994,"Lipid profiles after the daily consumption of an oat-based cereal: A controlled crossover trial","Poulter N., Chang C.L., Cuff A., Poulter C., Sever P., Thom S.",00029165,"American Journal of Clinical Nutrition",59, 1,7,0,0,2,2,0,9
1994,"Consistent responses of the human vascular smooth muscle cell in culture: Implications for restenosis","Munro E., Chan P., Patel M., Betteridge L., Gallagher K., Schachter M., Sever P., Wolfe J.",07415214,"Journal of Vascular Surgery",20, 3,15,0,0,0,0,0,15
1994,"How well are we managing blood pressure? [9]","Sever P.",01406736,"Lancet",344, 8928,3,0,0,0,0,0,3
1994,"Management targets and thresholds for treatment","Sever P.S.",00071420,"British Medical Bulletin",50, 2,0,0,0,0,0,0,0
1993,"Pravastatin once daily in hypercholesterolaemia: A U.K. study","Ritter J.M., Sever P., Brassfield T.",02694727,"Journal of Clinical Pharmacy and Therapeutics",18, 6,1,0,0,0,0,0,1
1993,"Ion channel involvement in the acute vascular effects of thiazide diuretics and related compounds","Calder J.A., Schachter M., Sever P.S.",00223565,"Journal of Pharmacology and Experimental Therapeutics",265, 3,13,1,0,0,1,0,14
1993,"Effect of calcium antagonists on endothelin-induced contraction of isolated human resistance arteries: Differences related to site of origin","Sunman W., Martin G., Hair W.M., Sever P.S., Hughes A.D.",09509240,"Journal of Human Hypertension",7, 2,1,0,0,0,0,0,1
1993,"Abnormal growth regulation of vascular smooth muscle cells by heparin in patients with restenosis","Chan P., Patel M., Betteridge L., Munro E., Schachter M., Wolfe J., Sever P.",01406736,"Lancet",341, 8841,29,0,0,0,0,0,29
1993,"The interaction between N-acetylcysteine, the superoxide anion and the endothelium in isolated resistance arteries","Sunman W., Sever P.S., Hughes A.D.",03065251,"British Journal of Clinical Pharmacology",35, 1,0,0,0,0,0,0,0
1993,"Structural changes in the heart and carotid arteries associated with hypertension in humans","Hughes A.D., Sinclair A.-M., Geroulakos G., Mayet J., Mackay J., Shahi M., Thom S., Nicolaides A., Sever P.S.",09509240,"Journal of Human Hypertension",7, 4,24,1,1,0,2,0,26
1993,"Management guidelines in essential hypertension: Report of the second working party of the British Hypertension Society","Sever P., Beevers G., Bulpitt C., Lever A., Ramsay L., Reid J., Swales J.",09598146,"British Medical Journal",306, 6883,296,3,3,0,6,0,302
1993,"The action of amlodipine on human subcutaneous resistance arteries studied in vitro","Garcha R.S., Sever P.S., Hughes A.D.",00223565,"Journal of Pharmacology and Experimental Therapeutics",265, 2,2,0,0,0,0,0,2
1993,"Unusual stress fracture in a cricketer [5]","Missouris C.G., Singer D.R.J., Hanson P., Sever P., MacGregor G.A.",01406736,"Lancet",342, 8886-8887,1,0,0,0,0,0,1
1993,"Free-radical scavengers, thiol-containing reagents and endothelin-dependent relaxation in isolated rat and human resistance arteries","Sunman W., Hughes A.D., Sever P.S.",01435221,"Clinical Science",84, 3,12,0,0,0,0,0,12
1993,"Inhibition of precursor responses to intravenous angiotensin II by a specific AT 1-receptor antagonist, GR117289C, in healthy subjects","Mackay J., Watson P., Blackwell C.P., Keene O.N., Baber N.S., Sever P.S.",03065251,"British Journal of Clinical Pharmacology",35, 1,2,0,0,0,0,0,2
1993,"Cellular biology of human intimal hyperplastic stenosis","Chan P., Munro E., Patel M., Betteridge L., Schachter M., Sever P., Wolfe J.",0950821X,"European Journal of Vascular Surgery",7, 2,19,1,1,0,2,0,21
1993,"Comparison of nifedipine and propranolol as second line agent for hypertension in black Kenyans","Poulter N.R., Sanderson J.E., Thompson A.V., Sever P.S., Chang C.L.",09598146,"British Medical Journal",306, 6878,4,0,0,0,0,0,4
1993,"Non-angiotensin effects of angiotensin-converting enzyme inhibitors","Sunman W., Sever P.S.",01435221,"Clinical Science",85, 6,26,1,1,0,2,0,28
1993,"Effect of nifedipine and glyceryl trinitrate on retinal blood flow in normal subjects","Sinclair A.-M., Hughes A.D., Sever P.S.",09509240,"Journal of Human Hypertension",7, 4,11,1,0,0,1,0,12
1992,"The effect of amlodipine upon vascular smooth muscle: Insights into the mode of action of calcium antagonists","Hughes A.D., Wijetunge S., Garcha R.S., Sever P.S.",02636352,"Journal of Hypertension",10, 11,0,0,0,0,0,0,0
1992,"Introduction: Protection during the crucial hours: Amlodipine, a new calcium antagonist in cardiovascular disease, Montreal 1990","Floras J.S., Sever P.S.",09509240,"Journal of Human Hypertension",6, 1,0,0,0,0,0,0,0
1992,"Direct vascular actions of hydrochlorothiazide and indapamide in isolated small vessels","Calder J.A., Schachter M., Sever P.S.",00142999,"European Journal of Pharmacology",220, 1,24,2,0,1,3,0,27
1992,"Mechanisms of action of cicletanine in human and guinea pig resistance arteries","Calder J.A., Schachter M., Sever P.S.",01602446,"Journal of Cardiovascular Pharmacology",19, 3,6,0,0,0,0,0,6
1992,"Management of elderly patients with sustained hypertension","Beard K., Bulpitt C., Mascie-Taylor H., O'Malley K., Sever P., Webb S.",09598146,"British Medical Journal",304, 6824,46,1,0,1,2,0,48
1992,"Interaction between cicletanine and the eicosanoid system in human subcutaneous resistance arteries","Calder J.A., Schachter M., Sever P.S.",00223573,"Journal of Pharmacy and Pharmacology",44, 7,7,0,0,0,0,0,7
1992,"Celiprolol [15]","Thom S., Hughes A., Schachter M., Sever P.",01406736,"Lancet",339, 8787,0,0,0,0,0,0,0
1992,"Neurally evoked responses of human isolated resistance arteries are mediated by both ? 1- and ? 2-adrenoceptors","Parkinson N.A., Thom McG. S., Hughes A.D., Sever P.S., Mulvany M.J., Nielsen H.",00071188,"British Journal of Pharmacology",106, 3,16,0,0,0,0,0,16
1992,"Peripheral presynaptic autoregulation by ? 2-adrenoceptors in man","Thom S.M., Goldberg P., Hughes A.D., Sever P.S.",02636352,"Journal of Hypertension",10, 11,0,0,0,0,0,0,0
1992,"Acute changes in haematological parameters on cessation of smoking","Bain B.J., Rothwell M., Feher M.D., Robinson R., Brown J., Sever P.S.",01410768,"Journal of the Royal Society of Medicine",85, 2,10,1,0,0,1,0,11
1992,"Anaphylactoid response to intravenous acetylcysteine [11]","Sunman W., Hughes A.D., Sever P.S.",01406736,"Lancet",339, 8803,17,1,0,1,2,0,19
1992,"Conn's syndrome can cause malignant hypertension","Sunman W., Rothwell M., Sever P.S.",09509240,"Journal of Human Hypertension",6, 1,7,0,0,0,0,0,7
1992,"Role of polyamines in angiotensin II-induced hypertension","Ibrahim J., Schachter M., Mitchell F., Sever P.S.",02636352,"Journal of Hypertension",10, 11,0,0,0,0,0,0,0
1991,"Amlodipine inhibition of alpha-agonist induced contraction in human resistance vessels","Garcha R., Schachter M., Hughes A., McG.Thom S., Sever P.",02636352,"Journal of Hypertension",9, 6,4,1,1,0,2,0,6
1991,"Management of coronary heart disease. Risk factors in hypertensive patients: Clinical experience with doxazosin: Summary","Sever P.S.",00028703,"American Heart Journal",121, 1,0,0,0,0,0,0,0
1991,"Introduction","Sever P.S.",00028703,"American Heart Journal",121, 1,0,0,0,0,0,0,0
1991,"Haemorheological changes in the very short term after abstention from tobacco by cigarette smokers","Rothwell M., Rampling M.W., Cholerton S., Sever P.S.",00071048,"British Journal of Haematology",79, 3,15,0,1,0,1,0,16
1991,"Determinants of left ventricular filling in hypertension","Shahi M., Thom S., Poulter N., Sever P.S., Foale R.A.",09509240,"Journal of Human Hypertension",5, 1,1,0,0,0,0,0,1
1991,"The effects of blood pressure reduction on abnormal left ventricular diastolic function in hypertensive patients","Shahi M., Thom S., Poulter N., Sever P.S., Foale R.A.",0195668X,"European Heart Journal",12, 9,2,0,0,0,0,0,2
1991,"The effects of adenosine triphosphate (ATP) and related purines on human isolated subcutaneous and omental resistance arteries","Martin G.N., Thom McG. S.A., Sever P.S.",00071188,"British Journal of Pharmacology",102, 3,14,0,0,1,1,0,15
1991,"The short-term effects of abstention from tobacco by cigarette smokers on blood viscosity and related parameters","Rampling M.W., Brown J.R., Robinson R.J., Feher M.D., Cholerton S., Sever P.S.",02715198,"Clinical Hemorheology",11, 5,3,0,0,0,0,0,3
1991,"Withdrawing antihypertensive treatment [1]","Sever P.S., Poulter N.R., Thom S.M.C.G., Sunman W., Crossman D.C., Aylett M., Ketchin S., Jackson P.R., Yeo W.W., Ramsay L.E., Jachuck S.J., Watson A.J., James M.A., MacConnell T.J.",09598146,"British Medical Journal",303, 6803,0,0,0,0,0,0,0
1991,"Hypertrichosis and verapamil [25]","Sever P.S.",01406736,"Lancet",338, 8776,4,0,0,0,0,0,4
1991,"First line treatment in hypertension (II)","Poulter N., Thom S., Sever P.",09598146,"British Medical Journal",302, 6768,1,0,0,0,0,0,1
1991,"Summary","Sever P.S.",00028703,"American Heart Journal",121, 1,0,0,0,0,0,0,0
1991,"Introduction","Sever P.S.",00028703,"American Heart Journal",121, 1,0,0,0,0,0,0,0
1990,"Regression of hypertensive left ventricular hypertrophy and left ventricular diastolic function","Shahi M., Thom S., Poulter N., Sever P.S., Foale R.A.",01406736,"Lancet",336, 8713,34,0,0,0,0,0,34
1990,"Intracellular free magnesium in a vascular smooth muscle cell line","Schachter M., Gallagher K.L., Sever P.S.",03005127,"Biochemical Society Transactions",18, 6,0,0,0,0,0,0,0
1990,"Intracellular glutathione and cytosolic calcium responses","Schachter M., Gallagher K.L., Sever P.S.",03005127,"Biochemical Society Transactions",18, 6,0,0,0,0,0,0,0
1990,"Measurement of intracellular magnesium in a vascular smooth muscle cell line using a fluorescent probe","Schachter M., Gallagher K.L., Sever P.S.",03044165,"Biochimica et Biophysica Acta - General Subjects",1035, 3,17,0,0,0,0,0,17
1990,"Muscarinic receptors of human prostatic stromal cells in vitro","Patel M.K., Schachter M., Sever P.S.",00142999,"European Journal of Pharmacology",183, 5,1,0,0,0,0,0,1
1990,"Investigation of opiate interaction with the sympathetic nervous system in the human forearm","Potocnik S.J., Thom S.M., Rutter P.C., Sever P.S.",00142999,"European Journal of Pharmacology",183, 3,0,0,0,0,0,0,0
1990,"Alpha2-adrenoceptors contol forearm skin blood flow","Irigoin-Guichandut M., Thom S.M., Potocnik S.J., Schachter M., Belcaro G., Sever P.S.",00142999,"European Journal of Pharmacology",183, 3,0,0,0,0,0,0,0
1990,"Acute changes in atherogenic and thrombogenic factors with cessation of smoking","Feher M.D., Rampling M.W., Brown J., Robinson R., Richmond W., Cholerton S., Bain B.J., Sever P.S.",01410768,"Journal of the Royal Society of Medicine",83, 3,26,0,0,0,0,0,26
1990,"Antihypertensive and adverse biochemical effects of bendrofluazide (II)","Poulter N., Sever P., Thom S.",09598146,"British Medical Journal",300, 6737,0,0,0,0,0,0,0
1990,"Risk factors for coronary heart disease - selecting appropriate antihypertensive therapy","Sever P.S., Reid J.L.",09509240,"Journal of Human Hypertension",4, 3,0,0,0,0,0,0,0
1990,"Alpha-blocker therapy; a possible advance in the treatment of diabetic hypertension - results of a cross-over study of doxazosin and atenolol monotherapy in hypertensive non-insulin dependent diabetic subjects","Feher M.D., Henderson A.D., Wadsworth J., Poulter C., Gelding S., Richmond W., Sever P.S., Elkeles R.S.",09509240,"Journal of Human Hypertension",4, 5,19,0,0,0,0,0,19
1990,"Low-density lipoproteins and platelets: Methodological considerations","Schachter M., Meraji S., Sever P.S., Bruckdorfer K.R.",02675323,"Journal of Drug Development, Supplement",3, 1,0,0,0,0,0,0,0
1990,"Phaeochromocytoma - Investigation and management of 10 cases","Deal J.E., Sever P.S., Barratt T.M., Dillon M.J.",00039888,"Archives of Disease in Childhood",65, 3,19,0,1,0,1,0,20
1990,"The Kenyan Luo migration study: observations on the initiation of a rise in blood pressure","Poulter N.R., Khaw K.T., Hopwood B.E.C., Mugambi M., Peart W.S., Rose G., Sever P.S.",09598146,"British Medical Journal",300, 6730,143,11,10,4,25,0,168
1989,"Multiple risk factor evaluation in a hypertension clinic","Thom S., Bunker J., Callister W., Poulter N., Sever P., Zographos D.",02636352,"Journal of Hypertension",7, 6,1,0,0,0,0,0,1
1989,"Oxidants and vascular smooth muscle","Schachter M., Gallagher K.L., Patel M.K., Sever P.S.",03005127,"Biochemical Society Transactions",17, 6,4,0,0,0,0,0,4
1989,"The effect of atrial natriuretic peptide on human isolated resistance arteries","Hughes A.D., Nielsen H., Sever P.S.",00071188,"British Journal of Pharmacology",97, 4,3,0,0,0,0,0,3
1989,"Specific binding of 125I SCH 23982, a selective dopamine (D1) receptor ligand to plasma membranes derived from human kidney cortex","Hughes A., Sever P.",00062952,"Biochemical Pharmacology",38, 5,2,0,0,0,0,0,2
1989,"Double-blind crossover versus parallel groups in hypertension","Sever P.S., Poulter N.R., Bulpitt C.S.",00028703,"American Heart Journal",117, 3,5,0,0,0,0,0,5
1989,"Treating mild hypertension. Agreement from the large trials","Swales J.D., Ramsay L.E., Coope J.R., Pocock S.J., Robertson J.I.S., Sever P.S., Shaper A.G.",02670623,"British Medical Journal",298, 6675,39,1,1,0,2,0,41
1989,"Autoradiographic localization of dopamine D1 receptors in human renal cortex","Hughes A., Schachter M., Sever P.",03005127,"Biochemical Society Transactions",17, 5,1,0,0,0,0,0,1
1989,"Effects of C18 fatty acids on phosphoinositide turnover in cultured human umbilical vein endothelial cells","Miles C.M.M., Schachter M., Sever P.S.",03005127,"Biochemical Society Transactions",17, 1,1,0,0,0,0,0,1
1989,"Introduction","Sever P.S.",00028703,"American Heart Journal",117, 1,0,0,0,0,0,0,0
1989,"Action of fenoldopam, a selective dopamine (DA1) receptor agonist, on isolated human arteries","Hughes A.D., Sever P.S.",03036847,"Blood Vessels",26, 2,13,0,0,0,0,0,13
1989,"Combination therapy with calcium-entry blockers and beta-adrenoceptor antagonists in hypertension","Sever P.",09203206,"Cardiovascular Drugs and Therapy",3, 1,0,0,0,0,0,0,0
1989,"The action of dopamine and vascular dopamine (DA1) receptor agonists on human isolated subcutaneous and omental small arteries","Hughes A.D., Sever P.S.",00071188,"British Journal of Pharmacology",97, 3,1,0,0,0,0,0,1
1989,"Haemorheological disturbances in non-insulin-dependent diabetes and the effects of concomitant hypertension","Rampling M.W., Feher M.D., Sever P.S., Elkeles R.S.",02715198,"Clinical Hemorheology",9, 1,2,0,0,0,0,0,2
1989,"Human vascular responses to endothelin-1: Observations in vivo and in vitro","Hughes A.D., Thom S.A.M., Woodall N., Schachter M., Hair W.M., Martin G.N., Sever P.S.",01602446,"Journal of Cardiovascular Pharmacology",13, 5,6,0,0,0,0,0,6
1989,"Postjunctional ? 2-adrenoceptors mediate vasoconstrictin in human subcutaneous resistance vessels","Nielsen H., Thom S., Hughes A.D., Martin G.N., Mulvany M.J., Sever P.S.",00071188,"British Journal of Pharmacology",97, 3,18,0,0,1,1,0,19
1989,"A hypothesis for the pathogenesis of essential hypertension: The initiating factors","Sever P.S., Poulter N.R.",02636352,"Journal of Hypertension",7, 1,11,0,0,0,0,0,11
1988,"?-Blockers, lipoproteins and non-insulin dependent diabetes","Feher M.D., Rains S.G.H., Richmond W., Torrens D., Wilson G., Wadsworth J., Sever P.S., Elkeles R.S.",00325473,"Postgraduate Medical Journal",64, 758,1,0,0,0,0,0,1
1988,"Size and site-dependent heterogeneity of human vascular responses in vitro","Hughes A.D., Thom S.A.M., Martin G.N., Nielsen H., Hair W.M., Schachter M., Sever P.S.",02636352,"Journal of Hypertension",6, 4,8,0,0,0,0,0,8
1988,"Acute lipoprotein changes associated with atenolol therapy for hypertension in non-insulin dependent diabetes","Feher M.D., Torrens D.J., Richmond W., Wadsworth J., Sever P.S., Elkeles R.S.",09509246,"Journal of Human Hypertension",2, 4,0,0,0,0,0,0,0
1988,"Low-density lipoproteins increase intracellular calcium in aequorin-loaded platelets","Dunn R.C., Schachter M., Miles C.M.M., Feher M.D., Tranter P.R., Bruckdorfer K.R., Sever P.S.",00145793,"FEBS Letters",238, 2,22,0,0,0,0,0,22
1988,"Factors infuencing blood pressure and heart rate variability in hypertensive humans","Floras J.S., Osman Hassan M., Vann Jones J., Osikowska B.A., Sever P.S., Sleight P.",0194911X,"Hypertension",11, 3,56,3,3,0,6,0,62
1988,"Influence of quinidine on nifedipine plasma pharmacokinetics","Oates N.S., Feher M.D., Perry H.E., Schmid B.J., Sever P.S., Idle J.R.",03065251,"British Journal of Clinical Pharmacology",25, 5,3,0,0,0,0,0,3
1988,"Action of dopamine on isolated human saphenous veins","Hughes A., Inkpen P., Sever P.",01602446,"Journal of Cardiovascular Pharmacology",11, 3,3,1,0,0,1,0,4
1988,"Peripheral adrenoceptors and type A behaviour","Schachter M., Sever P.S.",01406736,"Lancet",1, 8583,0,0,0,0,0,0,0
1988,"Ex vivo effects of acute nifedipine administration on platelet aggregation in man: Lack of correlation with plasma concentrations","Feher M.D., Schmid B.J., Rampling M., Schachter M., Sever P.S.",09529500,"Journal of Drug Development",1, 1,0,0,0,0,0,0,0
1988,"Diabetic hypertension - the importance of fibrinogen and blood viscosity","Feher M.D., Rampling M.W., Sever P.S., Elkeles R.S.",09509246,"Journal of Human Hypertension",2, 2,3,0,0,0,0,0,3
1988,"Comparison between oral and intravenous fat tolerance tests in normolipidaemic subjects","Feher M.D., Torrens D., Richmond W., Sever P.S., Elkeles R.S.",00185043,"Hormone and Metabolic Research",20, 3,2,0,0,0,0,0,2
1988,"Metabolism and pharmacokinetics of two formulations of nifedipine","Feher M.D., Oates N.S., Schmid B.J., Perry H.E., Sever P.S., Idle J.R.",09529500,"Journal of Drug Development",1, 2,0,0,0,0,0,0,0
1988,"De novo cardiac beta adrenoceptor synthesis in adult rats under normoxic and hypoxic conditions","Winter R.J.D., Inkpen P.M., Dickinson K.E.J., Rudd R.M., Sever P.S.",00086363,"Cardiovascular Research",22, 3,1,0,0,0,0,0,1
1988,"Direct effect of ?-human atrial natriuretic peptide on human vasculature in vivo and in vitro","Hughes A., Thom S., Goldberg P., Martin G., Sever P.",01435221,"Clinical Science",74, 2,8,0,0,1,1,0,9
1988,"Higher blood pressures of urban migrants from an African low-blood pressure population are not due to selective migration","Poulter N.R., Khaw K.T., Sever P.S.",08957061,"American Journal of Hypertension",1, 3,8,2,1,1,4,0,12
1988,"Consequences of impaired arterial baroreflexes in essential hypertension: Effects on pressor responses, plasma noradrenaline and blood pressure variability","Floras J.S., Osmam Hassan M., Vann Jones J., Osikowska B.A., Sever P.S., Sleight P.",02636352,"Journal of Hypertension",6, 7,36,2,0,0,2,0,38
1987,"Calcium antagonists and diuretics as combined therapy","Sever P.S., Poulter N.R.",02636352,"Journal of Hypertension",5, 4,8,0,1,0,1,0,9
1987,"No evidence for a direct vasodilatory effect of celiprolol on human vasculature in vivo or in vitro","Hughes A., Martin G., Goldberg P., Thom S., Sever P.",01602446,"Journal of Cardiovascular Pharmacology",10, 5,1,0,0,0,0,0,1
1987,"Characterization of neuropeptide Y receptors in rabbit kidney: Preliminary comparisons with rat and human kidney","Schachter M., Miles C.M.M., Leys K., Sever P.S.",01602446,"Journal of Cardiovascular Pharmacology",10, 12,2,0,0,0,0,0,2
1987,"The effect of atrial natriuretic peptide on human blood vessels","Hughes A.D., Nielsen H., Thom S., Martin G.N., Sever P.S.",02636352,"Journal of Hypertension",5, 5,4,0,0,0,0,0,4
1987,"A double-blind, placebo-controlled, crossover trial to investigate the additive hypotensive effect of a diuretic (mefruside) to that produced by nifedipine","Poulter N., Thompson A.V., Sever P.S.",01602446,"Journal of Cardiovascular Pharmacology",10, 10,3,0,0,0,0,0,3
1987,"Endothelium-dependent relaxation in isolated human arteries and veins","Thom S., Hughes A., Martin G., Sever P.S.",01435221,"Clinical Science",73, 5,27,0,0,0,0,0,27
1987,"Current opinion on the management of hypertension and cardiovascular risk factors","Sever P.S.",00070947,"British Journal of Clinical Practice",41, 54,0,0,0,0,0,0,0
1987,"Ergometrine and bronchospasm.","Hill H., Geraghty I., Hughes A., Sever P.S., Schachter M.",00032409,"Anaesthesia",42, 10,0,0,0,0,0,0,0
1987,"Autoradiographic localisation of NPY receptors in rabbit kidney: Comparison with rat, guinea-pig and human","Leys K., Schachter M., Sever P.",00142999,"European Journal of Pharmacology",134, 2,11,0,0,0,0,0,11
1986,"Heterogeneity between soluble human and rabbit splenic ?2-adrenoceptors","McKernan R.M., Dickinson K.E.J., Miles C.M.M., Sever P.S.",00062952,"Biochemical Pharmacology",35, 20,0,0,0,0,0,0,0
1986,"Vasoactive intestinal peptide as a bronchodilator in severe asthma","Morice A.H., Sever P.S.",01969781,"Peptides",7, 1,4,0,0,0,0,0,4
1986,"A comparison of the ventilatory, cardiovascular and metabolic effects of salbutamol, aminophylline and vasoactive intestinal peptide in normal subjects","Morice A.H., Schofield P., Keal E.E., Sever P.S.",03065251,"British Journal of Clinical Pharmacology",22, 2,4,0,0,0,0,0,4
1986,"Moderate potassium supplementation: ineffective in black normotensives.","Poulter N.R., Sever P.S.",0012835X,"East African Medical Journal",63, 12,3,0,1,0,1,0,4
1986,"1985 - the year of the hypertension trials: interpreting the results","Sever P.S.",01656147,"Trends in Pharmacological Sciences",7, C,2,0,0,0,0,0,2
1986,"Autoradiographic localisation of VIP receptors in human lung","Leys K., Morice A.H., Madonna O., Sever P.S.",00145793,"FEBS Letters",199, 2,5,0,0,0,0,0,5
1986,"Tissue specific modulation of ?-adrenoceptor number in rats with chronic hypoxia with an attenuated response to down-regulation by salbutamol","Winter R.J.D., Dickinson K.E.J., Rudd R.M., Sever P.S.",01435221,"Clinical Science",70, 2,8,0,1,0,1,0,9
1986,"Adrenaline, bronchoconstriction, and asthma","Morice A., Sever P., Ind P.",09598146,"British Medical Journal",293, 6546,0,0,0,0,0,0,0
1986,"Characterisation of a high-affinity VIP receptor in human lung parenchyma","Schachter M., Dickinson K.E.J., Miles C.M., Sever P.S.",00145793,"FEBS Letters",199, 1,2,0,0,0,0,0,2
1986,"Pulmonary clearance of vasoactive intestinal peptide","Barrowcliffe M.P., Morice A., Jones J.G., Sever P.S.",00406376,"Thorax",41, 2,8,0,0,0,0,0,8
1985,"In vivo and in vitro studies of ?2-adrenoceptor responses in human vascular smooth muscle","Thom S., Hayes R., Calvete J., Sever P.S.",01602446,"Journal of Cardiovascular Pharmacology",7, 6,2,0,0,0,0,0,2
1985,"The release of the endothelium derived relaxing factor from isolated human arteries","Thom S.A., Hughes A.D., Martin G.N., Sever P.S.",02636352,"Journal of Hypertension",3, 3,6,0,0,0,0,0,6
1984,"Vasoactive intestinal peptide as a bronchodilator in asthmatic subjects","Morice A.H., Unwin R.J., Sever P.S.",01969781,"Peptides",5, 2,0,0,0,0,0,0,0
1984,"VIP as bronchodilator","Morice A., Unwin R., Sever P.",01406736,"Lancet",1, 8374,1,0,0,0,0,0,1
1983,"Vasoactive intestinal peptide causes bronchodilatation and protects against histamine-induced bronchoconstriction in asthmatic subjects","Morice A., Unwin R.J., Sever P.S.",01406736,"Lancet",2, 8361,26,1,2,1,4,0,30
1983,"Non-pharmacological control of blood pressure","Sever P.S.",00325473,"Postgraduate Medical Journal",59, 3,0,0,0,0,0,0,0
1983,"Treatment of angina pectoris with nifedipine","Idle J.R., Sever P.S.",09598146,"British Medical Journal",286, 6382,1,0,0,0,0,0,1
1982,"The peripheral alpha-agonist effects of clonidine do not alleviate orthostatic hypotension in progressive autonomic failure","Cleary J., Mathias C.J., Bannister R., Sever P.",01435221,"Clinical Science",63, 3,0,0,0,0,0,0,0
1982,"Agonist regulation of ?-adrenergic receptor responses in man","Davies I.B., Mathias C.J., Sudera D., Sever P.S.",01602446,"Journal of Cardiovascular Pharmacology",4, 1,3,0,0,0,0,0,3
1982,"Unequivocal synthesis and characterisation of dopamine 3- and 4-O-sulphates","Osikowska B.A., Idle J.R., Swinbourne F.J., Sever P.S.",00062952,"Biochemical Pharmacology",31, 13,1,0,0,0,0,0,1
1981,"Racial differences in blood pressure: genetic and environmental factors","Sever P.S.",00325473,"Postgraduate Medical Journal",57, 674,2,0,0,0,0,0,2
1981,"Endogenous agonist regulation of ?-adrenoceptors in man","Davies I.B., Sudera D., Sever P.S.",01435221,"Clinical Science",61, 7,8,0,0,0,0,0,8
1981,"Pitfalls in the synthesis and authentication of dopamine-O-sulfates","Idle J.R., Osikowska B.A., Sever P.S., Swinbourne F.J.",00071188,"British Journal of Pharmacology",74, 4,0,0,0,0,0,0,0
1981,"The actions of saralasin on the renal circulation of man and dog: Evidence for a sympathetic neural component to vasoconstriction","Wilcox C.S., Lewis P.S., Sever P.S., Peart W.S.",00142972,"European Journal of Clinical Investigation",11, 2 I,1,0,0,0,0,0,1
1981,"Changes in plasma renin activity after hypoglycaemia in sympathectomized man","Frier B.M., Corral R.J.M., Pritchard J.L., Sever P.S.",01435221,"Clinical Science",61, 2,0,0,1,0,1,0,1
1981,"Levodopa: Long-term impact on Parkinson's disease","Bannister R., Sever P., Davies B.",09598146,"British Medical Journal",283, 6285,0,0,0,0,0,0,0
1981,"Pindolol in postural hypotension: the case for caution","Daies B., Bannister R., Mathias C., Sever P.",01406736,"Lancet",2, 8253,1,0,0,0,0,0,1
1980,"Preoperative localization of a phaeochromocytoma using plasma noradrenaline concentrations in multiple-site samples","Moss S., Greenbaum R., Sever P.S.",01410768,"Journal of the Royal Society of Medicine",73, 2,0,0,0,0,0,0,0
1980,"Comparison of the kinetics of infused with exercise-released plasma noradrenaline in man","Cope L., Davies I.B., Lightman S.L., Sever P.S.",01435221,"Clinical Science",59, 3,0,0,0,0,0,0,0
1980,"Phaeochromocytoma","Sever P.S., Roberts J.C., Snell M.E.",0300595X,"Clinics in Endocrinology and Metabolism",9, 3,2,1,0,0,1,0,3
1980,"Effect of propranolol on heart rate, blood pressure and plasma noradrenaline during coitus in the rabbit","Gordon D., Roddis S.A., Sever P.S.",01435221,"Clinical Science",59, 4,0,0,0,0,0,0,0
1980,"Indomethacin treatment of postural hypotension in autonomic failure","Bleddyn Davies I., Bannister R., Sever P.S.",09598146,"British Medical Journal",280, 6208,0,0,0,0,0,0,0
1980,"The pressor actions of noradrenaline and angiotension II in chronic autonomic failure treated with indomethacin","Davies I.B., Bannister R., Hensby C., Sever P.S.",03065251,"British Journal of Clinical Pharmacology",10, 3,9,0,0,0,0,0,9
1980,"Blood-pressure and its correlates in urban and tribal Africa","Sever P.S., Gordon D., Peart W.S., Beighton P.",01406736,"Lancet",2, 8185,36,1,1,1,3,0,39
1979,"Ethnic differences in blood pressure with observations on noradrenaline and renin. I. A working population","Sever P.S., Peart W.S., Meade T.W.",10641963,"Clinical and Experimental Hypertension",1, 6,4,0,0,0,0,0,4
1979,"Ethnic differences in blood pressure with observations on noradrenaline and renin. II. A hospital hypertensive population","Sever P.S., Peart W.S., Davies I.B.",10641963,"Clinical and Experimental Hypertension",1, 6,3,0,1,0,1,0,4
1979,"Sympathetic reflex responses during treatment of essential hypertension with hydrallazine and oxprenolol","Davies I.B., Sever P.S., Rosenthal T.",03065251,"British Journal of Clinical Pharmacology",8, 1,0,0,0,0,0,0,0
1979,"The pressor actions of noradrenaline, angiotensin II and saralasin in chronic autonomic failure treated with fludrocortisone","Davies B., Bannister R., Sever P., Wilcox C.",03065251,"British Journal of Clinical Pharmacology",8, 3,15,0,0,1,1,0,16
1979,"False transmitters and migraine","Sever P.S.",01406736,"Lancet",1, 8111,6,1,0,0,1,0,7
1978,"Plasma noradrenaline concentrations during isometric exercise","Vecht R.J., Graham G.W.S., Sever P.S.",00070769,"British Heart Journal",40, 11,4,0,0,0,0,0,4
1978,"Are racial differences in essential hypertension due to different pathogenetic mechanisms?","Sever P.S., Peart W.S., Meade T.W., Davies I.B., Gordon D., Tunbridge R.D.",01444107,"Clinical science and molecular medicine. Supplement",4, ,1,0,0,0,0,0,1
1978,"Changes in plasma noradrenaline concentration following sympathetic stimulation by gradual tilting","Rosenthal T., Birch M., Osikowska B., Sever P.S.",00086363,"Cardiovascular Research",12, 3,2,0,0,0,0,0,2
1978,"Fludrocortisone in the treatment of postural hypotension: Altered sensitivity to pressor agents","Davies I.B., Bannister R.G., Sever P.S., Wilcox C.S.",03065251,"British Journal of Clinical Pharmacology",6, 5,4,1,1,0,2,0,6
1978,"Indomethacin for Shy-Drager syndrome","Bannister R., Davies B., Sever P.",01406736,"Lancet",1, 8077,0,0,0,0,0,0,0
1978,"Pressor amines and monoamine-oxidase inhibitors for treatment of postural hypotension in autonomic failure. Limitations and hazards","Davies B., Bannister R., Sever P.",01406736,"Lancet",1, 8057,9,0,0,0,0,0,9
1977,"Cardiovascular reflexes and biochemical responses in progressive autonomic failure","Bannister R., Sever P., Gross M.",00068950,"Brain",100, 2,9,0,2,1,3,0,12
1977,"Pressor amines in the treatment of neurogenic postural hypotension. Limitations and hazards","Davies B., Bannister R., Sever P.",03065251,"British Journal of Clinical Pharmacology",4, 6,0,0,0,0,0,0,0
1977,"Plasma-noradrenaline in essential hypertension.","Sever P.S., Osikowska B., Birch M., Tunbridge R.D.",01406736,"Lancet",1, 8021,2,1,0,1,2,0,4
1977,"Hypertensive crisis in patients with phaeochromocytoma given metoclopramide","Sever P.S.",01406736,"Lancet",1, 8013,5,0,0,0,0,0,5
1976,"Urinary metabolites of p hydroxyamphetamine in man, rat and guinea pig","Sever P.S., Dring L.G., Williams R.T.",00498254,"Xenobiotica",6, 6,0,0,0,1,1,0,1
1976,"Receptor sensitivity in schizophrenia","Sever P.S.",01406736,"Lancet",1, 7954,0,0,0,0,0,0,0
1976,"Tolerance to amphetamine in two species (rat and guinea pig) that metabolize it differently","Sever P.S., Caldwell J., Tecwyn Williams R.",00332917,"Psychological Medicine",6, 1,0,0,0,0,0,0,0
1976,"Alterations in plasma noradrenaline concentration in response to postural change in normal subjects, in patients with autonomic failure and in essential hypertension","Osikowska B.A., Sever P.S.",03065251,"British Journal of Clinical Pharmacology",3, 5,0,0,0,0,0,0,0
1976,"On the fourth cranial nerve.","Gordon D., Sever P.S.",01406736,"Lancet",2, 7983,0,0,0,0,0,0,0
1975,"The metabolism of (-) ephedrine in man","Sever P.S., Dring L.G., Williams R.T.",00316970,"European Journal of Clinical Pharmacology",9, 2-3,9,0,1,0,1,0,10
1974,"Species differences in amphetamine tolerance","Sever P.S., Caldwell J.",0021793X,"Journal de Pharmacologie",5, 2,0,0,0,0,0,0,0
1974,"The biochemical pharmacology of abused drugs. II. Alcohol and barbiturates","Caldwell J., Sever P.S.",00099236,"Clinical Pharmacology and Therapeutics",15, 5 I,0,0,0,0,0,0,0
1974,"The biochemical pharmacology of abused drugs. III. Cannabis, opiates, and synthetic narcotics","Caldwell J., Sever P.S.",00099236,"Clinical Pharmacology and Therapeutics",16, 6,0,0,0,0,0,0,0
1974,"Evidence against the involvement of false neurotransmitters in tolerance to amphetamine induced hyperthermia in the rat","Sever P.S., Caldwell J., Williams R.T.",00223573,"Journal of Pharmacy and Pharmacology",26, 10,0,0,0,0,0,0,0
1974,"The effects of indomethacin on the development of tolerance to amphetamine induced hyperthermia. Are prostaglandins involved?","Sever P.S., Trelinski M.",00223573,"Journal of Pharmacy and Pharmacology",26, 8,0,0,0,0,0,0,0
1974,"On the mechanism of the hyperthermia induced by amphetamine in the rat","Caldwell J., Sever P.S., Trelinski M.",00223573,"Journal of Pharmacy and Pharmacology",26, 10,0,0,0,0,0,0,0
1974,"The biochemical pharmacology of abused drugs. I. Amphetamines, cocaine, and LSD","Caldwell J., Sever P.S.",00099236,"Clinical Pharmacology and Therapeutics",16, 4,13,0,0,0,0,0,13
1974,"Evidence against a role for p hydroxy norephedrine in amphetamine tolerance","Caldwell J., Sever P.S.",0021793X,"Journal de Pharmacologie",5, 2,0,0,0,0,0,0,0
1973,"The metabolism of hydroxyamphetamines in man and animals: 4' hydroxyl[14C]amphetamine (Paredrine)","Sever P.S., Dring L.G., Williams R.T.",03005127,"Biochemical Society Transactions",1, 5,1,0,0,0,0,0,1
1973,"The metabolism of amphetamine in dependent subjects","Sever P.S., Caldwell J., Dring L.G., Williams R.T.",00316970,"European Journal of Clinical Pharmacology",6, 3,6,0,0,1,1,0,7
1969,"The effects of antihypertensive therapy on carotid vascular structure in man","Mayet J., Stanton A.V., Sinclair A.-M., Mackay J., Shahi M., Foale R.A., Nicolaides A., Poulter N.R., Sever P.S., Thom S.A., Hughes A.D.",00086363,"Cardiovascular Research",3, 4,0,0,0,0,0,0,0
